Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Onyx’s Transformative Year: From Productive Partner To Big Cap Contender?

Mar 19 2013

Related Content

Hang Onto The Launch: Investor Outlook Is Brighter For Some Biotechs

Aug 20 2012

How <em>Kyprolis </em>Overcame Serious Safety Fears To Reach Myeloma Market With Clean Label

Jul 30 2012

Onyx <em>Kyprolis</em> Launch Strategy Includes Speedy Delivery, Premium Price

Jul 20 2012

Takeda Reaffirms Oncology Goals With $8.8 Billion Millennium Acquisition

Apr 10 2008

With <em>Kyprolis</em> Advancing, Millennium Stakes Faith In Oral <em>Velcade </em>Successor

Dec 24 2012

Hang Onto The Launch: Investor Outlook Is Brighter For Some Biotechs

Sep 12 2012

Related Companies

Onyx Pharmaceuticals, Inc.

Bristol Myers Squibb Company

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

Incyte Corporation

Seagen Inc.

Regeneron Pharmaceuticals, Inc.

Sanofi

Astellas Pharma, Inc.

Bayer AG

Bayer AG

Bayer AG

Bayer AG

Mayo Clinic

Johnson & Johnson

Pfizer Inc.

Gilead Sciences, Inc.

NPS Pharmaceuticals, Inc.

Additional Topics

Europe United States Clinical Trials Pricing Strategies Launches Deals Business Strategies BioPharmaceutical

More from Global Vision

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window